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Among the nonpharmacological therapies, pulmonary rehabilitation (PR) is particularly appropriate
for patients with chronic respiratory impairment who, despite any optimal drug management, are still
symptomatic and experience restriction in every day activities. Pulmonary rehabilitation performed in
inpatient, outpatient, or home settings demonstrates short- and long-term clinical efficacy. Although
disease severity does not inherently dictate candidacy for exercise training, the degree ofphysiological
and functional impairment may influence setting in which the training should occur. Therefore,
inpatient rehabilitation is generally best-suited for the most sick and most disabled patients. The
overall results from the literature confirm that the inpatient setting for a PR program is a feasible
option and does not necessarily result in higher direct costs when balanced against duration and
effectiveness in terms of improved outcomes. Chronic Respiratory Disease 2005; 2: 43-46
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Introduction
The goals of pulmonary rehabilitation (PR) are to
reduce symptoms, decrease disability, increase partici-
pation in physical and social activities, and to improve
the overall quality of life for individuals with chronic
respiratory disease.' 3 These goals are achieved
through several processes (including exercise training,
patient and family education, psychosocial and
behavioural intervention) that are implemented by a
multidisciplinary team of health care professionals.
One of the most comprehensive definitions of PR is
that promoted by the American Thoracic Society:2
'Pulmonary rehabilitation is a multidisciplinary program
of care for patients with chronic respiratory impairment
that is individually tailored and designed to optimise
physical and social performance and autonomy'.
Among all the nonpharmacological therapies, PR is
particularly appropriate for patients with chronic
respiratory impairment who, despite optimal drug
management, are still symptomatic and experience
restriction in every day activities.4 Patients with chronic
obstructive pulmonary disease (COPD) as well as
patients with other respiratory conditions may be
candidates for PR,5 adhering to the same principles of
ameliorating secondary morbidity.1-3 For example,
the degree of airway obstruction or hyperinflation of
chronic obstructive pulmonary disease does not
change appreciably with PR, but reversal of muscle
deconditioning and better pacing enable patients to
walk farther with less breathlessness. Thus, it should be
emphasized that symptoms, disability and handicap,6'7
and not the severity of physiological impairment of the
lungs, dictate the need for PR.
Measures to assess impairments other than FEVI,
and disability in chronic respiratory diseases are useful
to evaluate the effectiveness of PR. So far, weakness
and dysfunction of peripheral8 and respiratory
muscles,9 anxiety and depression,'0 and abnormalities
of nutrition and body composition" have been shown
to be responsive following PR in COPD patients with
different degrees of severity of airway obstruction.
Referral to PR is more often reserved for those with
far-advanced lung disease;12 however, referral at an
earlier stage would also facilitate preventive strategies
such as smoking cessation, or better attitude and long-
term adherence to exercise. The health economic
benefits ofPR are only just beginning to be explored, '3
but reductions in hospital admission frequency,
duration of stay, exacerbation rate, general practitioner
home visits, and bronchodilator usage have all been
reported.3"4
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Settings for PR
Despite substantial variability in program structure, PR
performed in inpatient,15 outpatient, 16'17 or home
settings18 has documented short and long-term clinical
efficacy. Nevertheless, PR programs are costly and
access to rehabilitation facilities is limited.'4 Fre-
quency, duration of session, length and location of
program are important determinants of the PR
outcomes. Both duration and location may profoundly
affect costs of a PR.2 As a result, a careful selection of
patients for PR is required and controversy still exists
regarding the most effective treatment schedule and
setting. 1 -
PR by setting may vary considerably in staff
availability, program duration, structure and individual
components. Many factors can influence the choice of
setting. These include the prerehabilitation physical,
functional and psychosocial status of the patient. The
local availability to the program, the logistics, the health
care reimbursement modality and stipulations, and
the patient's preference are also considered important.2
The various characteristics of outpatient, inpatient or
home-based PR are listed in Table 1.
Inpatient rehabilitation is generally best suited for
the most sick and most disabled patients.19 In
particular, PR for bed bound patients having problems
of weaning and recovering from major surgery is
gaining professional acceptance in hospital intensive
care units.20
Outpatient rehabilitation (hospital-based or commu-
nity-based) is currently the most widely available
modality and, as such, has the potential to benefit
the majority. A certain level of functional ability,
however, must already be present for patients to
physically attend outpatient sessions two to three times
a week.1-3,17
Table 1 Characteristics of PR according to different settings
Inpatient Outpatient Home-based
Medical monitoring ± + + ++ + /
Nursing/RT care +++ ++ +
Staff resources +++ ++ +
Exercise equipment ++ ++ +/
Total costs +++ ++ +
Cost/effectiveness ++±+ ± ±
Transportation ++
Reimbursement +++ ± + + /
Group support +-+ + ++
Family participation + + / + + +
Patient's convenience + + + + + +
Long-term adherence +/ + +±+
RT, respiratory therapist; + or- means the level of achievement and/or
needing.
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The concept of home-based pulmonary rehabilita-
tion may vary considerably among programs. For
example, a home-based program may provide regular
supervized home exercise and education given by
physiotherapists for patients who are too dyspnoeic to
attend outpatient rehabilitation.2' The principal advan-
tages of home-based rehabilitation are convenience for
the patient and family members and a familiar
environment for training and the acquisition of
techniques.
Inpatient PR
Clinical effectiveness (RCT versus observational
studies)
In the last decades, clinical studies dealing with the
effectiveness of PR almost universally describe those
with COPD. In the two most relevant and recently
published meta-analysis of randomized and controlled
trials, only three out of 23 studies22 and two out of 20
studies23 have been performed in an inpatient setting.
Therefore, only about 10% of the total amount of
consistent literature of PR refers to effects obtained in
hospitalized patients.
Overall, four major RCTs were identified in COPD
patients with different degrees of severity and in
comparison with the untreated controls. Cockcroft
et al.24 demonstrated that exercise tolerance in terms
of 12-minute walking distance significantly improved
in a group of moderate to severe symptomatic COPD
trained in hospital by showing a treatment effect of
+77 m in comparison with the control group. A
significant improvement in exercise tolerance and
health-related quality of life (HRQoL), as assessed by
the CRD questionnaire,25 has been obtained after eight
weeks of comprehensive PR in another study by
treating COPD of similar degree of severity. 5
Moreover, Vallet et al.26 were also able to show that
symptom-limited oxygen consumption and maximal
ventilation have increased by -20% in a group of
moderate COPD patients after training at the heart rate
corresponding to their metabolic ventilatory threshold,
four times a week for a two-month period. An
additional study by Nava et al.27 demonstrated that
early and progressive PR is effective (by improving
exercise tolerance and decreasing dyspnoea) in very
disabled COPD patients admitted to a respiratory ICU
after and episode of acute respiratory failure leading to
mechanical ventilation.
Several other observational, quasi-randomized or
historically controlled studies have also shown that PR
programs of variable duration delivered in different
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settings might improve symptoms and optimize
function in COPD patients of different degree of
severity. 1-3,22 Some of these studies were performed
on hospitalized patients, thus showing that generic
measures of HRQoL,28 functional status,29 anxiety
and depression, '301 as well as other outcome
measures28-31 may be improved by comprehensive
PR programs.
Among these non-randomized trials, only two
studies have compared the benefits of PR delivered as
inpatient or outpatient program. Couser et al. 32 have
shown that comprehensive two-month outpatient and
two-week inpatient PR programs are as beneficial in
older severe COPD patients as they are in younger
individuals with similar lung function abnormalities. A
more recent study,33 confirmed that a shorter inpatient
PR program may result in improvement of exercise
capacity and symptoms similar to those obtained after
a longer outpatient PR program in patients with mild to
moderate chronic airflow obstruction.
Taking other non-COPD conditions into account, PR
intervention has proven its efficac3y in hospitalized
patients. In one RCT, Fiatarone et al. 4 have shown that
high-intensity resistance exercise training is a feasible
and effective means of counteracting muscle weakness
and physical frailty in very elderly people resident in
long-term bed facilities. Furthermore, in an observa-
tional case study, Wijkstra et al.35 demonstrated that
physical activity and mobility can be maintained in
very disabled and long-term ventilated patients (with
restrictive underlying diagnosis) admitted and treated
in a specialised ventilatory unit.
Costs
So far, PR has been demonstrated to be a cost-effective
treatment in COPD patients,12 providing a quality
adjusted life years (QALY) gain ranging from 0.05 to
0.1 (benefit sustained for six months and then declined
until 18 months). A comprehensive review from
the DARE database36 has shown that total cost of the
service has been estimated as 300-600 Euros (200-
400 GBP) per patient. Cost savings might also accrue in
terms ofreduced general practitioner consultations and
hospital admissions,16 although there is still insufficient
evidence for this to be quantified.
However, these calculations have been based on the
outpatient model, which is currentlgr considered as the
most efficient form of delivery PR. No definitive cost
comparison among different settings has been made. A
recent study performed in Italy comparing cost and
program duration in patients with mild to moderate
chronic airway obstruction,33 has demonstrated that a
short, intensive inpatient PR program, with up to 12
sessions held five days per week, led to comparable
gains in exercise tolerance at a lower cost, compared to
a longer outpatient program (exercise three times per
week for about eight weeks). The decreased cost was
attributable to fewer total sessions and the elimination
of transportation costs.33
It is not clear whether a similar cost result could be
achieved in a hospital setting in different countries,
given the possible different criteria for admission to
inpatient rehabilitation and the different healthcare
reimbursement climate.
Conclusions
Rehabilitation for patients with chronic respiratory
disorders is well established and widely accepted as a
mean of enhancing standard therapy in order to
alleviate symptoms and optimize function. In particu-
lar, it has been shown to be cost-effective in COPD
patients, independent of disease stage. Exercise
training/pulmonary rehabilitation may be undertaken
in an inpatient, outpatient or home-based setting,
depending on the individual needs of the patient and
available resources.
Although disease severity does not inherently dictate
suitability for exercise training, the degree of
physiological and functional impairment does deter-
mine the optimal setting in which the training should
occur.37 Sick patients with severe functional impair-
ment who need 24-hour medical or nursing intervention
may benefit from inpatient rehabilitation. Even
ventilator-dependent or elderly disabled patients who
are medically stable may undergo rehabilitation with
assistance from experienced hospital staff. While in
some countries, patients who live too far to attend
outpatient PR programs can undergo inpatient PR, this
cannot be the case all over the world.38
However, inpatient setting for PR program is a
feasible option and it does not necessarily result in
higher direct costs when duration and improved
outcomes are taken into account.
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